Isabella Strahan was diagnosed with brain cancer in 2023. Isabella Strahan, the daughter of "Good Morning America" co-anchor Michael Strahan is opening up about the biggest lesson she learned ...

The proportion of people who have never smoked being diagnosed with lung cancer is rising, with new research pointing to air pollution as a growing contributor to lung cancer around the world.

Lung cancer screening aims to find lung cancer early. This is when there are more treatment options available and there is the best chance of treating it successfully. In the UK, the National ...

Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited. In a cohort of patients with liver metastases ...

Objectives To investigate the sex-specific association between smoking and lung cancer. Design Systematic review and meta-analysis. Data sources We searched PubMed and EMBASE from 1 January 1999 to 15 ...

The scan found signs of cancer, and a biopsy confirmed that she had lung cancer. The diagnosis was a shock to Ciaccio, who considered herself healthy and had never smoked. "I still can't grasp the ...

tumor markers are signs of specific types of tumors. Doctors look for these markers to aid in the diagnosis and treatment of lung cancer. Doctors use several tests to measure cancer and tumor ...

Lung cancer is a form of cancer wherein abnormal cells start to grow in the lungs in an uncontrolled way. According to World Cancer Research Fund, there were nearly 2.4 million new cases of lung ...

Chemotherapy for lung cancer is used for different purposes depending on the type and stage of cancer you have. This includes achieving cancer remission, shrinking a tumor before surgery, killing ...

Lung cancer, one of the four most common types of cancer in the UK, sees over 49,000 new cases each year, according to Cancer Research UK. This disease is triggered by an uncontrolled growth of ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...